DALIRESP vs OTEZLA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. DALIRESP and OTEZLA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DALIRESP	OTEZLA
Rating	70/100	72/100
Pharmacy pays	~$10.09 /30	—
Type	RX	RX
Active ingredient	ROFLUMILAST	APREMILAST
Manufacturer	Astrazeneca	Amgen Inc
Dosage forms	Tablet	Tablet, Kit
Drug class	Phosphodiesterase 4 Inhibitor	Phosphodiesterase 4 Inhibitor
Boxed warning	None	None
Half-life	—	about 6 to 9 hours (terminal elimination half-life)
Treats	Chronic Obstructive Pulmonary Disease	Psoriatic Arthritis

daliresp otezla

Rating

70/100

72/100

Pharmacy pays

~$10.09 /30

—

Type

Active ingredient

ROFLUMILAST

APREMILAST

Manufacturer

Astrazeneca

Amgen Inc

Dosage forms

Tablet

Tablet, Kit

Drug class

Phosphodiesterase 4 Inhibitor

Boxed warning

None

Half-life

—

about 6 to 9 hours (terminal elimination half-life)

Treats

Chronic Obstructive Pulmonary Disease

Psoriatic Arthritis

Frequently asked questions

Which is better-rated, Daliresp or Otezla?

By our independent rating, Otezla scores higher — 3.6 vs 3.5 out of 5 for Daliresp. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Daliresp and Otezla?

Daliresp contains Roflumilast, while Otezla contains Apremilast — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.